Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Multiple Sclerosis

Free Subscription 03.08.2026 1 Ann Neurol 1 Arch Phys Med Rehabil 1 J Neuroimmunol 1 J Neurol 1 J Neurol Neurosurg Psychiatry 2 J Neurol Sci 1 Mult Scler 1 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. AMEZCUA L, Reder AT, Bernitsas E, Monson NL, et al
   Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical Trial.
   Ann Neurol. 2026 Jul 30. doi: 10.1002/ana.78290.
   PubMed         Abstract available
   
   

   
   Arch Phys Med Rehabil

2. RUBIO-ARIAS JA, Villena-Molina S, Andreu-Carvaca L, Leon-Ariza HH, et al
   Structured exercise training for fatigue management in multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.
   Arch Phys Med Rehabil. 2026 Jul 30:S0003-9993(26)00850.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

3. MAUCERI VA, Di Mare D, Rinaldi F, Di Paola A, et al
   Lesion burden determines the incremental diagnostic value of intrathecal IgG oligoclonal bands synthesis in multiple sclerosis.
   J Neuroimmunol. 2026;420:579045.
   PubMed         Abstract available
   
   

   
   J Neurol

4. ACHILLE M, Copetti M, Guerra T, Ferri C, et al
   Prognostic factors in paediatric-onset multiple sclerosis: a narrative review.
   J Neurol. 2026;273:495.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

5. HEDSTROM AK, Thomas O, Strid P, Hillert J, et al
   HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2026 Jul 31:jnnp-2026-338964.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

6. DOU F, Yuan X, Liu S
   Comment on "Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission".
   J Neurol Sci. 2026;489:126120.
   PubMed        
   
   
7. MURALEEDHARAN T, Mohammed WB, Nevil S, Charles SA, et al
   Comment on "Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission".
   J Neurol Sci. 2026;489:126119.
   PubMed        
   
   

   
   Mult Scler

8. SHIPLEY J, Zhu C, Sanfilippo PG, Skibina O, et al
   Association between pregnancy timing and disability outcomes in women with mild relapse-onset multiple sclerosis.
   Mult Scler. 2026 Jul 29:13524585261464055. doi: 10.1177/13524585261464055.
   PubMed         Abstract available
   
   

   
   Neurology

9. SCHOOF L, Heijnen R, Hogenboom L, Van Kempen ZLE, et al
   Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis.
   Neurology. 2026;107:e218379.
   PubMed         Abstract available
   
   

   
   PLoS One

10. ZHU K, Barberio J, Tsao N, Mor A, et al
    Trends in the incidence of asthma, atopic dermatitis, and multiple sclerosis before, during, and after the COVID-19 pandemic in a US claims database.
    PLoS One. 2026;21:e0355103.
    PubMed         Abstract available
    
    
11. DE HERDT D, Lefevere E, Brouwers V, Hartvig L, et al
    Selective GPR17 antagonism enhances structural and functional recovery in animal models of demyelination.
    PLoS One. 2026;21:e0354525.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum